N

Novocure (NVCR)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Novocure (NVCR)

NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell divisi... Read more

Open
USD17.52
High
USD18.00
Low
USD17.52
52 Week High
USD34.13
Monthly Return
3.00%
Revenue
622M

Daily Vol.
157.98k
Avg. Daily Vol.
1.59M
Market Cap.
2.0B
52 Week Low
14.17
Annual Return
9.40%

Stock News

Foresight: Eye-Net, in Collaboration with Orange’s Mobile Application, Achieves 99% Detection Rate in French Urban Mobility Trials

Foresight: Eye-Net, in Collaboration with Orange’s Mobile Application, Achieves 99% Detection Rate in French Urban Mobility Trials

Yahoo

This early-warning indicator is telling the stock market that a recession is more likely

This early-warning indicator is telling the stock market that a recession is more likely

MarketWatch

What If Mistras Isn't As Broken As It Looks?

What If Mistras Isn't As Broken As It Looks?

SeekingAlpha

Boeing: Leadership Changes And A Warning For The Bulls

Boeing: Leadership Changes And A Warning For The Bulls

SeekingAlpha

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.